Table 4.
Changes in anthropomorphic variables and markers of metabolic health after two weeks of consuming the additive enhanced (experimental) diet.
Baseline | +7 days | +14 days | P value* | |
---|---|---|---|---|
Anthropomorphic Variables | ||||
Weight (lbs) | 166.1 ± 30.6 | 165.2 ± 30.4 | 164.7 ± 29.9† | 0.002 |
Systolic blood pressure (mmHg) | 119 ± 13 | 113 ± 22 | 114 ± 12 | 0.10 |
Diastolic blood pressure (mmHg) | 66 ± 10 | 66 ± 10 | 65 ± 10 | 0.55 |
Markers of Insulin Resistance and Metabolic Health | ||||
Fasting glucose (mg/dL) | 79.7 ± 6.2 | 80.5 ± 6.2 | 79.3 ± 6.4 | 0.32 |
Fasting insulin (μU/L) | 7.6 ± 3.1 | 8.9 ± 4.1† | 6.7 ± 3.2 | 0.002 |
HOMA-IR | 1.5 ± 0.6 | 1.8 ± 0.9† | 1.3 ± 0.7 | <0.001 |
Leptin (ng/ml) | 9.7 (6.9, 13.7) | -- | 8.3 (5.8, 11.7)† | 0.01 |
Adiponectin (μg/ml) | 8.1 ± 3.9 | -- | 7.7 ± 3.6 | 0.11 |
Inflammatory Cytokines | ||||
Interleukin 6 (pg/ml) | 0.54 ± 0.23 | -- | 0.61 ± 0.31 | 0.11 |
Interleukin 8 (pg/ml) | 3.9 ± 1.9 | -- | 4.4 ± 4.4 | 0.54 |
Tumor necrosis factor a (pg/ml) | 1.7 ± 0.5 | -- | 1.9 ± 0.9 | 0.18 |
HOMA-IR, homeostatic model assessment-insulin resistance. Values are presented as arithmetic mean ± standard deviation or geometric mean (95 confidence interval).
P for time indicating the statistical significance of changes in outcome variables over time
P<0.05 when compared to baseline values